Viewing Protocol Section

Home

Stocks

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

eRecord

Main Search All Studies All Organizations Report Bug

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT00060515

Ignite Creation Date: 2024-05-05 @ 11:30 AM

Last Modification Date: 2024-10-26 @ 9:08 AM

Study NCT ID: NCT00060515

Protocol Section: NCT00060515

Start Identification Module Data

Expand Identification Module Data

Brief Title: RG2133 235-Tri-O-Acetyluridine in Mitochondrial Disease

Official Title: An Open-Label Dose-Escalation Phase I Study to Asses the Safety Tolerability Pharmacokinetics and Pharmacodynamics of RG2133 235-Tri-O-Acetyluridine in the Treatment of Inherited Mitochondrial Diseases

Acronym: None

Organization: Repligen Corporation

Organization Class: INDUSTRY

Organization Study ID: RG2133-01

Start Status Module Data

Status Verified Date: 2005-08

Overall Status: TERMINATED

Study First Submit Date:

Study First Submit QC Date:

Last Update Submit Date:

Status:

Start Sponsor Collaborators Module Data

Investigator:

Lead Sponsor: Repligen Corporation

Lead Sponsor Class: INDUSTRY

Lead Sponsor: Repligen Corporation

Start Oversight Module Data

Description Module:

Study Last Update Post Date Type(Status Module):

Attachment: Upload